Therapeutic antibodies with reduced side effects
A therapeutic protein, such as a therapeutic antibody, that is modified with a compound that inhibits binding of the protein to its therapeutic target, thereby reducing side effects caused by the protein.
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | HERMAN WALDMANN LUIS RICARDO SIMOES DA SILVA GRACA MARK RAYMOND FREWIN LISA KIM GILLILAND |
description | A therapeutic protein, such as a therapeutic antibody, that is modified with a compound that inhibits binding of the protein to its therapeutic target, thereby reducing side effects caused by the protein. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2003260686BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2003260686BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2003260686BB23</originalsourceid><addsrcrecordid>eNrjZDAIyUgtSixILS3JTFZIzCvJTMpPyUwtVijPLMlQKEpNKU1OTVEozkxJVUhNS0tNLinmYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxjqFGBgbGRmYGZhZmTk5GxkQqAwB8mizQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Therapeutic antibodies with reduced side effects</title><source>esp@cenet</source><creator>HERMAN WALDMANN ; LUIS RICARDO SIMOES DA SILVA GRACA ; MARK RAYMOND FREWIN ; LISA KIM GILLILAND</creator><creatorcontrib>HERMAN WALDMANN ; LUIS RICARDO SIMOES DA SILVA GRACA ; MARK RAYMOND FREWIN ; LISA KIM GILLILAND</creatorcontrib><description>A therapeutic protein, such as a therapeutic antibody, that is modified with a compound that inhibits binding of the protein to its therapeutic target, thereby reducing side effects caused by the protein.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091126&DB=EPODOC&CC=AU&NR=2003260686B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091126&DB=EPODOC&CC=AU&NR=2003260686B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HERMAN WALDMANN</creatorcontrib><creatorcontrib>LUIS RICARDO SIMOES DA SILVA GRACA</creatorcontrib><creatorcontrib>MARK RAYMOND FREWIN</creatorcontrib><creatorcontrib>LISA KIM GILLILAND</creatorcontrib><title>Therapeutic antibodies with reduced side effects</title><description>A therapeutic protein, such as a therapeutic antibody, that is modified with a compound that inhibits binding of the protein to its therapeutic target, thereby reducing side effects caused by the protein.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAIyUgtSixILS3JTFZIzCvJTMpPyUwtVijPLMlQKEpNKU1OTVEozkxJVUhNS0tNLinmYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxjqFGBgbGRmYGZhZmTk5GxkQqAwB8mizQ</recordid><startdate>20091126</startdate><enddate>20091126</enddate><creator>HERMAN WALDMANN</creator><creator>LUIS RICARDO SIMOES DA SILVA GRACA</creator><creator>MARK RAYMOND FREWIN</creator><creator>LISA KIM GILLILAND</creator><scope>EVB</scope></search><sort><creationdate>20091126</creationdate><title>Therapeutic antibodies with reduced side effects</title><author>HERMAN WALDMANN ; LUIS RICARDO SIMOES DA SILVA GRACA ; MARK RAYMOND FREWIN ; LISA KIM GILLILAND</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2003260686BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>HERMAN WALDMANN</creatorcontrib><creatorcontrib>LUIS RICARDO SIMOES DA SILVA GRACA</creatorcontrib><creatorcontrib>MARK RAYMOND FREWIN</creatorcontrib><creatorcontrib>LISA KIM GILLILAND</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HERMAN WALDMANN</au><au>LUIS RICARDO SIMOES DA SILVA GRACA</au><au>MARK RAYMOND FREWIN</au><au>LISA KIM GILLILAND</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Therapeutic antibodies with reduced side effects</title><date>2009-11-26</date><risdate>2009</risdate><abstract>A therapeutic protein, such as a therapeutic antibody, that is modified with a compound that inhibits binding of the protein to its therapeutic target, thereby reducing side effects caused by the protein.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2003260686BB2 |
source | esp@cenet |
subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
title | Therapeutic antibodies with reduced side effects |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T16%3A29%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HERMAN%20WALDMANN&rft.date=2009-11-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2003260686BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |